ENDOBIOS biotech has a dual specialty expertise: the disruptive discovery and development of new bioactive natural products from microorganisms (bacteria, fungi), and the first-time biotechnological application related to endobacterial symbionts in the eukaryotic cytoplasm.
Besides custom services, ENDOBIOS also provides consulting in new natural products discovery and development (for Pharma, Agro or Cosmetic application), and in endosymbiotic bacteria living in eukaryotic hosts.
Our currently most advanced project is the mid-preclinical trial development of a drug candidate (isolated from a marine fungus) which is active against central nervous system disorders.
ENDOBIOS has proprietary methods for the induction of novel neuropathic agents, and also of antibiotics from microbial sources.
Company Details
- Employees
- 1
- Address
- Lisbon, Portugal, Oo
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://endobios.com/
- Keywords
- Bioactive natural products derived from fungi, bacteria and microalgae, Biotechnology, Drug discovery, Drug development, Early identification of natural products directly in extracts, Neuropathies, antibiotics, antifungals, endosymbioses, Proprietary methods for the induction of cryptic natural products derived from microbial sources, Consulting.
- HQ
- Lisbon, Portugal
Endobios Biotech Questions
Endobios Biotech's website is https://endobios.com/
Endobios Biotech's LinkedIn profile is https://www.linkedin.com/company/endobios-biotech
Endobios Biotech has
1 employees.
View email and phone details for 1
employees at Endobios Biotech.
Endobios Biotech's industry is
Biotechnology Research
Endobios Biotech's top competitors are
Capa Biotech,
🧬 Doublehelix Agency,
Fulldna Portugal,
Dart Diagnostics,
T3 - Targeted Therapies Today,
Bz Biotech,
Numar Biotech,
Madeinsea, Produção Marinha Sustentável,
Biofuse - Biotech Simplified Ltd,
Myglico Inc.
Endobios Biotech's categories are Biotechnology Research
